Are environmental factors for atopic eczema in ISAAC Phase Three due to reverse causation?

Rutter, Charlotte; Silverwood, Richard J.; Williams, Hywel C.; Elwood, Philippa; Asher, Innes; Garcia-Marcos, Luis; Strachan, David P.; Pearce, Neil; Langan, Sinead M.; ISAAC Phase Three Group

Abstract

Some previously described environmental associations for atopic eczema (AE) may be due to reverse causation. We explored the role of reverse causation by comparing individual- and school-level results for multiple AE risk factors.

ISAAC Phase Three surveyed children within schools (the sampling unit) on AE symptoms and potential risk factors. We assessed the effect of these risk factors on AE symptoms using mixed-effect logistic regression models, first with individual-level exposure data and second with school-level exposure prevalence.

546,348 children from 53 countries were included. At age 6-7 the strongest individual-level associations were with current paracetamol use (odds ratio=1.45, 95% confidence interval 1.37-1.54), which persisted at school-level (1.55, 1.10-2.21), antibiotics (1.41, 1.34-1.48) and early life paracetamol use (1.28, 1.21-1.36) with the former persisting at school-level while the latter was no longer observed (1.35, 1.00-1.82 and 0.94, 0.69-1.28 respectively). At age 13-14 the strongest associations at individual-level were with current paracetamol use (1.57, 1.51-1.63) and open-fire cooking (1.46, 1.33-1.62); both were stronger at school-level (2.57, 1.84-3.59 and 2.38, 1.52-3.73 respectively). Association with exposure to heavy traffic (1.31, 1.27-1.36) also persisted at school-level (1.40, 1.07-1.82).

Most individual- and school level effects were consistent tending to exclude reverse causation.

Citation

Rutter, C., Silverwood, R. J., Williams, H. C., Elwood, P., Asher, I., Garcia-Marcos, L., Strachan, D. P., Pearce, N., Langan, S. M., & ISAAC Phase Three Group. (2019). Are environmental factors for atopic eczema in ISAAC Phase Three due to reverse causation?. Journal of Investigative Dermatology, 139(5), 1023-1036. https://doi.org/10.1016/j.jid.2018.08.035

• Journal Article Type: Article
• Acceptance Date: Aug 30, 2018
• Online Publication Date: Dec 4, 2018
• Publication Date: May 1, 2019
• Deposit Date: Sep 5, 2018
• Publicly Available Date: Dec 4, 2018
• Journal: Journal of Investigative Dermatology
• Print ISSN: 0022-202X
• Electronic ISSN: 1523-1747
• Publisher: Elsevier
• Peer Reviewed: Peer Reviewed
• Volume: 139
• Issue: 5
• Pages: 1023-1036
• DOI: https://doi.org/10.1016/j.jid.2018.08.035
• Public URL: https://nottingham-repository.worktribe.com/output/1060865
• Publisher URL: https://www.sciencedirect.com/science/article/pii/S0022202X18328124
• Contract Date: Sep 5, 2018